These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 225242)

  • 21. Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors.
    Nissi R; Talvensaari-Mattila A; Kuvaja P; Pääkkö P; Soini Y; Santala M
    Anticancer Res; 2015 Feb; 35(2):973-6. PubMed ID: 25667483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotype and K-RAS mutation in mucinous ovarian adenocarcinoma with mural nodule of high-grade sarcoma: case report.
    Desouki MM; Fadare O; Kanbour A; Kanbour-Shakir A
    Int J Gynecol Pathol; 2014 Mar; 33(2):186-90. PubMed ID: 24487474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
    Virk R; Lu D
    Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
    Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
    Cao D; Ji H; Ronnett BM
    Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of OCIA domain containing 2 during stepwise progression of ovarian mucinous tumor.
    Nagata C; Kobayashi H; Sakata A; Satomi K; Minami Y; Morishita Y; Ohara R; Yoshikawa H; Arai Y; Nishida M; Noguchi M
    Pathol Int; 2012 Jul; 62(7):471-6. PubMed ID: 22726067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.
    Heinzelmann-Schwarz VA; Scolyer RA; Scurry JP; Smith AN; Gardiner-Garden M; Biankin AV; Baron-Hay S; Scott C; Ward RL; Fink D; Hacker NF; Sutherland RL; O'Brien PM
    J Clin Pathol; 2007 Jun; 60(6):622-6. PubMed ID: 16822880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
    Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
    Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?
    Kim KR; Lee HI; Lee SK; Ro JY; Robboy SJ
    Am J Surg Pathol; 2007 Apr; 31(4):546-54. PubMed ID: 17414101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphological and histochemical evaluation of the stroma of epithelial mucinous neoplasms of the ovaries].
    Malarewicz A
    Ginekol Pol; 1979 Jul; 50(7):597-600. PubMed ID: 159222
    [No Abstract]   [Full Text] [Related]  

  • 32. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
    Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cytokeratins 7 and 20 in ovarian neoplasia.
    Cathro HP; Stoler MH
    Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
    Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literature.
    Hershkovitz D; Vlodavsky E; Simon E; Ben-Izhak O
    Pathol Int; 2013 Dec; 63(12):611-4. PubMed ID: 24422958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
    Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
    Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.
    Lin WL; Kuo WH; Chen FL; Lee MY; Ruan A; Tyan YS; Hsu JD; Chiang H; Han CP
    Ann Surg Oncol; 2011 Aug; 18(8):2388-94. PubMed ID: 21347793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
    Karaferic A; Jovanovic D; Jelic S
    J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer.
    Chao WR; Lee MY; Lin WL; Chen CK; Lin JC; Koo CL; Sheu GT; Han CP
    Hum Pathol; 2014 Apr; 45(4):810-6. PubMed ID: 24656091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of immunohistochemistry in diagnosis and differential diagnosis of ovarian tumors].
    Li Q; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):280-4. PubMed ID: 19575906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.